Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of bortezomib in treating patients who have advanced
cancer and kidney dysfunction. Bortezomib may stop the growth of cancer cells by blocking the
enzymes necessary for cancer cell growth.